Mon, March 25, 2013
Fri, March 22, 2013
Thu, March 21, 2013
Wed, March 20, 2013
Tue, March 19, 2013
Mon, March 18, 2013
Fri, March 15, 2013

Christopher Raymond Maintained (BMRN) at Buy with Increased Target to $70 on, Mar 20th, 2013


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-70-on-mar-20th-2013.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI


Christopher Raymond of Piper Sandler, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Increased Target from $64 to $70 on, Mar 20th, 2013.

Christopher has made no other calls on BMRN in the last 4 months.



There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 0 agree with Christopher's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Christopher


  • Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $71 on, Tuesday, February 12th, 2013
  • Martin Auster of "UBS" Maintained at Strong Buy with Increased Target to $67 on, Friday, February 1st, 2013

Publication Contributing Sources